AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations

Canada News News

AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations
Canada Latest News,Canada Headlines
  • 📰 NBCNewYork
  • ⏱ Reading Time:
  • 53 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 63%

AstraZeneca, Boehringer Ingelheim and other drugmakers have filed at least eight lawsuits seeking to declare the Medicare price talks unconstitutional.

have filed at least eight separate lawsuits in recent months seeking to declare the negotiations unconstitutional. Another lawsuit from the Chamber of Commerce, one of the biggest lobbying groups nationwide, is seeking a preliminary injunction, which aims to block the negotiations before Oct. 1.

The pharmaceutical industry fiercely opposes the process because it believes it will threaten its revenue growth, profits and drug innovation. However, analysts expect minimal financial losses for companies, at least initially, since most of the drugs selected already face upcoming patent expirations that will likely weigh on revenue.

For example, Farxiga will lose its market exclusivity in 2026, which will open up the market to generic alternatives. That's the same year renegotiated prices are set to take effect. The Inflation Reduction Act, which passed Congress last year in narrow party-line votes, empowered Medicare to negotiate drug prices for the first time in the program's six-decade history. The law is the central pillar in the Biden administration's efforts to control rising drug prices and was a major victory for the Democratic Party.

The administration named the first round of drugs set to face price talks last month, kicking off a lengthy negotiation process that will end in August 2024.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NBCNewYork /  🏆 270. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Special Section: Health Care on the Hill: Medicare cuts jeopardize patient accessSpecial Section: Health Care on the Hill: Medicare cuts jeopardize patient access“Health Care on the Hill: Medicare cuts jeopardize patient access” is a Special Advertising Supplement to The Washington Times.
Read more »

6 Pitfalls to Avoid When Choosing Medicare AdvantageOnly 3 in 10 Medicare beneficiaries shop around during open enrollment, according to a 2022 analysis from KFF, a health policy nonprofit - and only 1 in 10 Medicare Advantage enrollees voluntarily switch plans.
Read more »

How a federal government shutdown may affect Social Security and MedicareHow a federal government shutdown may affect Social Security and MedicareLawmakers face a looming deadline to pass a spending bill to prevent a federal government shutdown. Here’s what that means for Social Security and Medicare.
Read more »

How a government shutdown would affect Medicare, Medicaid benefitsHow a government shutdown would affect Medicare, Medicaid benefitsWhile CMS is partially shielded from the impending tumult, it will retain fewer than half of its employees until a shutdown ends.
Read more »

How a government shutdown would affect Medicare and Medicaid benefitsHow a government shutdown would affect Medicare and Medicaid benefitsWhile the Centers for Medicare & Medicaid Services is partially shielded from the impending tumult, it will retain fewer than half of its employees until a shutdown ends.
Read more »

Medicare's open enrollment is coming. Don't miss this important step.Medicare's open enrollment is coming. Don't miss this important step.Medicare plans change from year to year, and so do your medical needs. Reviewing the ANOC is a crucial part of Medicare's open enrollment period.
Read more »



Render Time: 2025-02-28 23:11:38